Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05866887 · ClinicalTrials.gov registry record · NA
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05866887 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 25 participants.
The verdict
NCT05866887, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers. The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.
Interventions
- BEHAVIORAL Sleep ALL Night
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-09-26 |
| Est. Completion | 2024-06-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05866887
The ClinicalTrials.gov registry entry for NCT05866887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sleep ALL Night is the first listed.
NCT05866887 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05866887 about?
NCT05866887 is a clinical study titled "Insomnia Prevention in Children With Acute Lymphoblastic Leukemia". The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers. The name of the intervention used in this re...
What is the current status of trial NCT05866887?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-09-26. Estimated completion is 2024-06-05.
What interventions are being tested in trial NCT05866887?
The interventions under investigation include: Sleep ALL Night (BEHAVIORAL).
Who is sponsoring clinical trial NCT05866887?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.